Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
28.7M
-
Shares change
-
-510K
-
Total reported value, excl. options
-
$155M
-
Value change
-
-$5.55M
-
Put/Call ratio
-
0.19
-
Number of buys
-
35
-
Number of sells
-
-23
-
Price
-
$5.40
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q4 2022
72 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q4 2022.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.7M shares
of 60.7M outstanding shares and own 47.36% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.77M shares), Deep Track Capital, LP (3.95M shares), Sands Capital Ventures, LLC (3.42M shares), Knollwood Investment Advisory, LLC (1.68M shares), Laurion Capital Management LP (1.21M shares), BlackRock Inc. (1.14M shares), GREAT POINT PARTNERS LLC (1.12M shares), VANGUARD GROUP INC (716K shares), MILLENNIUM MANAGEMENT LLC (666K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (564K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.